A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer
Clinical trial NCT04228601 · COMPLETED
Trial details
- NCT number
- NCT04228601
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-21
- Primary completion
- 2022-08-10
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.